We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov Menu

Clinical Assessment of a Multifocal Contact Lens for People Who Use Reading Glasses Only

This study has been completed.
ClinicalTrials.gov Identifier:
First Posted: December 31, 2010
Last Update Posted: June 29, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Alcon Research ( CIBA VISION )
The purpose of this trial is to evaluate the use of multifocal contact lenses in people who use reading glasses only.

Condition Intervention
Presbyopia Device: Lotrafilcon B multifocal contact lens

Study Type: Interventional
Study Design: Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Clinical Assessment of a New Multifocal Contact Lens With Emmetropic Presbyopes

Resource links provided by NLM:

Further study details as provided by Alcon Research ( CIBA VISION ):

Primary Outcome Measures:
  • Overall Convenience With Contact Lenses [ Time Frame: 3 weeks of wear ]
    Overall convenience with contact lenses, as interpreted by the participant and reported on a questionnaire as a single, retrospective evaluation of 3 weeks of wear time. Overall convenience is measured on a 4-point scale: 1=very satisfied; 2=satisfied; 3=dissatisfied; 4=very dissatisfied. Results were reported as a percentage of participants who responded, "very satisfied" or "satisfied."

Enrollment: 103
Study Start Date: December 2010
Study Completion Date: February 2011
Primary Completion Date: February 2011 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Lotrafilcon B multifocal
Lotrafilcon B multifocal contact lenses worn bilaterally for 3 weeks on a daily wear basis
Device: Lotrafilcon B multifocal contact lens
Commercially marketed, silicone hydrogel, multifocal, soft contact lenses FDA-approved for up to 4 weeks recommended replacement schedule and up to 6 nights of extended (overnight) wear.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   40 Years to 48 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Is between 40 and 48 years of age (inclusive).
  • Has read and signed the Informed Consent.
  • Is willing and able to follow instructions and maintain the appointment schedule.
  • Wears reading spectacles for close work.
  • Other protocol-defined inclusion/exclusion criteria may apply.

Exclusion Criteria:

  • Eye injury or surgery within twelve weeks of enrollment.
  • Evidence of systemic or ocular abnormality, infection, or disease likely to affect successful wear of contact lenses or use of accessory solutions.
  • Currently enrolled in a clinical trial.
  • Has worn contact lenses previously.
  • Other protocol-defined inclusion/exclusion criteria may apply.
  Contacts and Locations
No Contacts or Locations Provided
  More Information

Responsible Party: CIBA VISION
ClinicalTrials.gov Identifier: NCT01268501     History of Changes
Other Study ID Numbers: P-319-C-019
First Submitted: December 29, 2010
First Posted: December 31, 2010
Results First Submitted: January 13, 2012
Results First Posted: February 9, 2012
Last Update Posted: June 29, 2012
Last Verified: February 2012

Additional relevant MeSH terms:
Refractive Errors
Eye Diseases